OrbiMed Advisors is part of a partnership interested in acquiring all of Kinnate Biopharma. Baker Brothers increased an investment in Madrigal Pharmaceuticals.
Kinnate Biopharma, Madrigal Pharma, and More Stocks See Action From Activist Investors
2023-11-24 10:00
OrbiMed Advisors is part of a partnership interested in acquiring all of Kinnate Biopharma. Baker Brothers increased an investment in Madrigal Pharmaceuticals.
You Might Like...
Meta’s Threads to Raise Stakes for Snap, Pinterest
Beats Studio Pro: Apple launches updated version of over-ear headphones
ChatGPT creator pulls AI detection tool due to 'low rate of accuracy'
Musk Calls for AI ‘Regulatory Structure,’ Warns Congress of Risk
QuSecure Expands its Board of Directors with Cisco Distinguished Engineer
Goldman Sachs Slashes Adani Group Stakes From Its ESG Funds
Yelp sues Texas to defend its labeling of crisis pregnancy centers
Barclays Analysts Hit by Bias Claim in Report About Controversial Pipeline